logo
  

Sandoz To Invest EUR 150 Mln In Austrian Facility To Strengthen Antibiotics Manufacturing

Sandoz, Novartis AG's (NVS) generics and biosimilars division, announced Monday plans for a joint investment with Austrian federal government for large-scale manufacture of active ingredients for penicillin products. The deal would strengthen antibiotics manufacturing in Europe.

Sandoz intends to invest more than 150 million euros over the next five years. The Austrian federal government would contribute or coordinate public funding totaling approximately 50 million euros towards the total investment.

Under the deal, the company plans to strengthen the long-term competitiveness of its integrated antibiotic manufacturing operations at Kundl facility in Austria, developing and introducing innovative manufacturing technology for both active pharmaceutical ingredients or APIs and finished dosage forms or FDFs.

The government funding would primarily support new process technology to produce API for penicillin products at Kundl. Sandoz would commit to related penicillin API production in Europe for the next 10 years, despite fierce global price competition, particularly from China.

The joint plan is subject to formal approvals by both parties. Sandoz and the Austrian government anticipate a formal closing of the agreement before the end of the year.

The deal is part of Austrian federal government's efforts to increase European-based production of essential medicines.

Sandoz noted that it produces enough penicillin products at Kundl to potentially meet all current Europe-wide demand.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Bea Lydecker's Naturals, Inc. is recalling six Living Free brand dietary supplement products citing undeclared soy lecithin, the U.S. Food and Drug Administration said. According to the agency, the labels declare lecithin but do not declare soy lecithin. Investment banking major Morgan Stanley plans to block employees and clients who are not fully vaccinated against COVID-19 from entering its New York offices, the Financial Times reported citing an internal memo. The policy is expected to come into effect on July 12, and all unvaccinated employees will lose building access from then onwards. Oklahoma City, Oklahoma -based Prairie Wolf Spirits, Inc. is recalling certain Prairie Wolf Distillery hand sanitizer packaged in containers that resemble water bottles, the U.S. Food and Drug Administration said. The product poses a risk of ingestion. The recall involves all lots of Prairie Wolf Distillery hand sanitizer packaged in 16.9 fluid ounce and 20 fluid ounce containers.
Follow RTT